Zobrazeno 1 - 5
of 5
pro vyhledávání: '"G F Pili"'
Autor:
Manca Em, G.B. Piredda, G F Pili, F. Lo Jacono, F. Logias, O Manca, A Barracca, G.L. Pisano, P. Carta
Publikováno v:
The Journal of Vascular Access. 6:182-186
Vascular access (VA) for hemodialysis (HD) is one of the most important clinical problems in end-stage renal disease (ESRD) patients because it can limit a life support system and can influence long-term dialysis patient survival. Nevertheless, VA be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53d8b4127583c9475d62f9e7f4c73cae
https://doi.org/10.1177/112972980500600405
https://doi.org/10.1177/112972980500600405
Publikováno v:
The Journal of Vascular Access. 4:68-72
The choice of vascular access in hemodialysis pediatric patients can be challenging, due to the small diameter of vessels. In the last 19 years, 38 arteriovenous fistulas (AVF) for hemodialysis have been created on 21 patients; 25 of them were radio-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e9dafbd682b6e06c8fd04fd13086409
https://doi.org/10.1177/112972980300400207
https://doi.org/10.1177/112972980300400207
Publikováno v:
The journal of vascular access. 3(3)
Frequently patients are started on hemodialysis after the placement of a central venous catheter (temporary or tunneled) in the internal jugular vein (IJV). Currenty this procedure is facilitated by ultrasound probes that improve the rate of success
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c334fad475cff41d1d12a710d308a9
https://pubmed.ncbi.nlm.nih.gov/17639474
https://pubmed.ncbi.nlm.nih.gov/17639474
Publikováno v:
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. 19(1)
Aging in the dialitic population currently shows the problem of vascular access for haemodialysis. The use of temporary catheters for haemodialysis has increased the risk of infections. DOQI guidelines underline this problem. We think that the thromb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b3a669b5f948746dded5a27b0bac7003
https://pubmed.ncbi.nlm.nih.gov/12165945
https://pubmed.ncbi.nlm.nih.gov/12165945
Publikováno v:
Renal failure. 20(3)
Gliclazide, a sulfonlyurea class molecule, is used to control glycaemic levels in non-insulin-dependent diabetes mellitus. Acute and chronic toxicity studies, conducted in various animal species, have demonstrated a very low toxicity. We report a pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d30bd21197c8bb027ea9211b47e497c
https://pubmed.ncbi.nlm.nih.gov/9606741
https://pubmed.ncbi.nlm.nih.gov/9606741